Eli Lilly, Gilead favorites at BofA forward of Q3 earnings

Symbol for the 3rd Quarter of the year. Hand turns dice and changes the expression Q2 to Q3.


Heading into the biopharma Q3 earnings season, Financial institution of America has taken a bullish stance on Eli Lilly (NYSE:LLY) and Gilead (NASDAQ:GILD) whereas elevating issues on COVID-era favorites resembling Pfizer (NYSE:PFE) and Regeneron (NASDAQ:REGN).

The top of the pandemic

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles